STAT3 Regulates Proliferation and Immunogenicity of the Ewing Family of TumorsIn Vitro
Open Access
- 18 January 2012
- journal article
- research article
- Published by Hindawi Limited in Sarcoma
- Vol. 2012, 1-6
Abstract
The Ewing sarcoma family of tumors (ESFT) represents an aggressive spectrum of malignant tumour types with common defining histological and cytogenetic features. To evaluate the functional activation of signal transducer and activator of transcription 3 (STAT3) in ESFT, we evaluated its activation in primary tissue sections and observed the functional consequences of its inhibition in ESFT cell lines. STAT3 was activated (tyrosine 705-phosphorylated) in 18 out of 31 primary tumours (58%), either diffusely (35%) or focally (23%). STAT3 was constitutively activated in 3 out of 3 ESFT cell lines tested, and its specific chemical inhibition resulted in complete loss of cell viability. STAT3 inhibition in ESFT cell lines was associated with several consistent changes in chemokine profile suggesting a role of STAT3 in ESFT in both cell survival and modification of the cellular immune environment. Together these data support the investigation of STAT3 inhibitors for the Ewing family of tumors.Keywords
Funding Information
- Bone Cancer Research Trust
This publication has 16 references indexed in Scilit:
- STAT3: A Target to Enhance Antitumor Immune Response2010
- The molecular pathogenesis of Ewing sarcomaCancer Biology & Therapy, 2010
- PAX5 Expression in Nonhematopoietic TissuesAmerican Journal of Clinical Pathology, 2010
- Persistently Activated Stat3 Maintains Constitutive NF-κB Activity in TumorsCancer Cell, 2009
- STAT3 is activated in a subset of the Ewing sarcoma family of tumoursThe Journal of Pathology, 2006
- Activated Epidermal Growth Factor Receptor–Stat-3 Signaling Promotes Tumor SurvivalIn vivoin Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoproteinJournal of Experimental Medicine, 2005
- Evaluation of potential Stat3-regulated genes in human breast cancerBiochemical and Biophysical Research Communications, 2005
- Persistent STAT3 Activation in Colon Cancer Is Associated with Enhanced Cell Proliferation and Tumor GrowthNeoplasia, 2005
- Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarraysOncogene, 2003